Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Latest filing published 13 Sept 2013 for Trius Therapeutics Inc.
Insider track record
Disclosed buys
0
Disclosed sells
8
Signal history
No signal scores available.
Philippe Prokocimer: trading record in brief
All filings by Philippe Prokocimer on record concern Trius Therapeutics Inc. We count 15 filings; the first trade dates from 22 August 2011 and the latest from 11 September 2013.
No open-market purchase appears, only 8 sales worth €266k. The rest of the record consists of 5 option exercises. So far in 2013, the count stands at no purchases and 5 sales.
Most recently, on 13 September 2013, the filings show a transaction in Trius Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Philippe Prokocimer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
12,190 sharesCommon StockSEC:0001209191-13-044236:0
82,022 sharesCommon StockSEC:0001209191-13-044236:1
2,000 shares@ US$8.14Common StockSEC:0001209191-13-034394:0
2,000 shares@ US$7.75Common StockSEC:0001209191-13-030218:0
12,000 shares@ US$7.93Common StockSEC:0001209191-13-029242:0
12,000 shares@ US$7.65Common StockSEC:0001209191-13-026617:0
6,244 shares@ US$0.52Common StockSEC:0001181431-12-019759:0
4,000 shares@ US$0.52Common StockSEC:0001181431-12-002869:0
1,687 shares@ US$7.45Common StockSEC:0001181431-11-054422:0
1,687 shares@ US$7.45Common StockSEC:0001181431-11-053932:0
4,000 shares@ US$0.52Common StockSEC:0001181431-11-052013:0
4,070 shares@ US$0.52Common StockSEC:0001181431-11-046729:0
12 of 12 declarations
